Streetbeat News

Products Services

BA

GE

GE Aerospace's CFO announced during a conference call that they are planning for the Boeing 777X's entry into service by mid-2025.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 4:02 pm

NVO

Novo Nordisk's executive mentioned that valuations of companies developing cardiometabolic drugs have increased, yet opportunities for acquisitions to enhance its obesity pipeline remain. The company plans to focus on injectable obesity drugs globally before introducing oral versions in higher-priced markets. High-dose oral semaglutide and oral amycretin are seen as key to winning in these markets based on efficacy.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 4:02 pm

GE

During the Investor Day, GE Aerospace's CFO announced expectations for the company to become price-cost positive in 2024, with the Leap program turning profitable next year. The 9x engine is anticipated to remain a challenge, while inflation headwinds are expected to ease by 2025. The company has planned for mid-single digit price increases next year.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 3:57 pm

WMT

Walmart has announced plans to open a new milk processing facility in Robinson, Texas, by 2026. This development is expected to create nearly 400 new local jobs and generate $350M in capital investment, according to Texas Governor Abbott.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 3:53 pm

CTLT

NVO

Novo Nordisk's CFO mentioned that if the Catalent deal does not close, Novo Nordisk will pursue more deals with contract drugmakers. Additionally, there is still opportunity for Novo Nordisk to acquire companies to enhance its obesity pipeline, as stated during a conference call.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 3:47 pm

CELZ

Creative Medical Technology Holdings' shares surged following the FDA's authorization for expanded access therapy using CELZ-20, indicating a positive development for the company and its stakeholders.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 3:42 pm

CERO

CERo Therapeutics' stock is trading higher following the announcement of their preclinical research publication on CER-1236, which targets Acute Myelogenous Leukemia tumor cells in human patients.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 3:40 pm

KR

Kroger is testing new initiatives such as customer pickup lockers, drive-thru lanes, and AI-enabled store routing technology to enhance its pickup business. The company anticipates stronger sales in the second half of the year, despite facing headwinds from SNAP benefits and lower inflation in the first half, as stated in a conference call.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 3:37 pm

GOLD

Barrick Gold CEO Mark Bristow discussed the factors driving gold to all-time highs, including global risks and geopolitical tensions. He criticized the North American economy for becoming accustomed to 'free money,' leading to increased debt and unsustainable businesses. Bristow also outlined Barrick Gold's strategy focusing on exploration and operational efficiency, with significant investments in greenfield projects and efforts to reduce gold mining costs.

Portfolio Pulse from Stjepan Kalinic

March 07, 2024 | 3:36 pm

KR

Kroger plans to complete 30 major store projects in 2024, including new stores, relocations, and expansions, focusing on higher-growth geographies, as stated in a conference call.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 3:32 pm